1,883 research outputs found
Galileo e l'Inquisizione : memorie storico-critiche dirette alla romana Accademia di Archeologia / da monsignor Marino Marini
Galileo e l'Inquisizione : memorie storico-critiche dirette alla romana Accademia di Archeologia / da monsignor Marino Marini
Roma : S. C. De propaganda fide, 1850
153 p. ; 22 c
Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity
Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression
Duchenne Muscular Dystrophy (DMD) is an X-linked neuromuscular disease which to date is incurable. The major cause of death is dilated cardiomyopathy however, its pathogenesis is unclear as existing cellular and animal models do not fully recapitulate the human disease phenotypes. In this study, we generated cardiac organoids from patient-derived induced pluripotent stem cells (DMD-COs) and isogenic-corrected controls (DMD-Iso-COs) and studied if DMD-related cardiomyopathy and disease progression occur in the organoids upon long-term culture (up to 93 days). Histological analysis showed that DMD-COs lack initial proliferative capacity, displayed a progressive loss of sarcoglycan localization and high stress in endoplasmic reticulum. Additionally, cardiomyocyte deterioration, fibrosis and aberrant adipogenesis were observed in DMD-COs over time. RNA sequencing analysis confirmed a distinct transcriptomic profile in DMD-COs which was associated with functional enrichment in hypertrophy/dilated cardiomyopathy, arrhythmia, adipogenesis and fibrosis pathways. Moreover, five miRNAs were identified to be crucial in this dysregulated gene network. In conclusion, we generated patient-derived cardiac organoid model that displayed DMD-related cardiomyopathy and disease progression phenotypes in long-term culture. We envision the feasibility to develop a more complex, realistic and reliable in vitro 3D human cardiac-mimics to study DMD-related cardiomyopathies
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein
BRAF is a serine/threonine kinase frequently mutated in human cancers. BRAF(V600E) mutated protein is targeted through the use of kinase inhibitors which are approved for the treatment of melanoma; however, their long-term efficacy is hampered by resistance mechanisms. The PROTAC-induced degradation of BRAF(V600E) has been proposed as an alternative strategy to avoid the onset of resistance. In this study, we designed a series of compounds where the BRAF kinase inhibitor encorafenib was conjugated to pomalidomide through different linkers. The synthesized compounds maintained their ability to inhibit the kinase activity of mutated BRAF with IC(50) values in the 40–88 nM range. Selected compounds inhibited BRAF(V600E) signaling and cellular proliferation of A375 and Colo205 tumor cell lines. Compounds 10 and 11, the most active of the series, were not able to induce degradation of mutated BRAF. Docking and molecular dynamic studies, conducted in comparison with the efficient BRAF degrader P5B, suggest that a different orientation of the linker bearing the pomalidomide substructure, together with a decreased mobility of the solvent-exposed part of the conjugates, could explain this behavior
Mobility shift of beta-dystroglycan as a marker of GMPPB gene-related muscular dystrophy
Background: Defects in glycosylation of alpha-dystroglycan (α-DG) cause autosomal-recessive disorders with wide clinical and genetic heterogeneity, with phenotypes ranging from congenital muscular dystrophies to milder limb girdle muscular dystrophies. Patients show variable reduction of immunoreactivity to antibodies specific for glycoepitopes of α-DG on a muscle biopsy. Recessive mutations in 18 genes, including guanosine diphosphate mannose pyrophosphorylase B (GMPPB), have been reported to date. With no specific clinical and pathological handles, diagnosis requires parallel or sequential analysis of all known genes. / Methods: We describe clinical, genetic and biochemical findings of 21 patients with GMPPB-associated dystroglycanopathy. / Results: We report eight novel mutations and further expand current knowledge on clinical and muscle MRI features of this condition. In addition, we report a consistent shift in the mobility of beta-dystroglycan (β-DG) on Western blot analysis of all patients analysed by this mean. This was only observed in patients with GMPPB in our large dystroglycanopathy cohort. We further demonstrate that this mobility shift in patients with GMPPB was due to abnormal N-linked glycosylation of β-DG. / Conclusions: Our data demonstrate that a change in β-DG electrophoretic mobility in patients with dystroglycanopathy is a distinctive marker of the molecular defect in GMPPB
Political cycle and reported labour incomes in Italy: Quasi-experimental evidence on tax evasion
The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes
Organisms have evolved to survive rigorous environments and are not prepared to thrive in a world of caloric excess and sedentary behavior. A realization that physical exercise (or lack of it) plays a pivotal role in both the pathogenesis and therapy of type 2 diabetes mellitus (t2DM) has led to the provocative concept of therapeutic exercise mimetics. A decade ago, we attempted to simulate the beneficial effects of exercise by treating t2DM patients with 3 weeks of daily hyperthermia, induced by hot tub immersion. The short-term intervention had remarkable success, with a 1 % drop in HbA1, a trend toward weight loss, and improvement in diabetic neuropathic symptoms. An explanation for the beneficial effects of exercise and hyperthermia centers upon their ability to induce the cellular stress response (the heat shock response) and restore cellular homeostasis. Impaired stress response precedes major metabolic defects associated with t2DM and may be a near seminal event in the pathogenesis of the disease, tipping the balance from health into disease. Heat shock protein inducers share metabolic pathways associated with exercise with activation of AMPK, PGC1-a, and sirtuins. Diabetic therapies that induce the stress response, whether via heat, bioactive compounds, or genetic manipulation, improve or prevent all of the morbidities and comorbidities associated with the disease. The agents reduce insulin resistance, inflammatory cytokines, visceral adiposity, and body weight while increasing mitochondrial activity, normalizing membrane structure and lipid composition, and preserving organ function. Therapies restoring the stress response can re-tip the balance from disease into health and address the multifaceted defects associated with the disease
The globalization of cultural eutrophication in the coastal ocean: causes and consequences
Coastal eutrophication caused by anthropogenic nutrient inputs is one of the greatest threats to the health of coastal estuarine and marine ecosystems worldwide. Globally, similar to 24% of the anthropogenic N released in coastal watersheds is estimated to reach coastal ecosystems. Seven contrasting coastal ecosystems subject to a range of riverine inputs of freshwater and nutrients are compared to better understand and manage this threat. The following are addressed: (i) impacts of anthropogenic nutrient inputs on ecosystem services; (ii) how ecosystem traits minimize or amplify these impacts; (iii) synergies among pressures (nutrient enrichment, over fishing, coastal development, and climate-driven pressures in particular); and (iv) management of nutrient inputs to coastal ecosystems. This comparative analysis shows that "trophic status," when defined in terms of the level of primary production, is not useful for relating anthropogenic nutrient loading to impacts. Ranked in terms of the impact of cultural eutrophication, Chesapeake Bay ranks number one followed by the Baltic Sea, Northern Adriatic Sea, Northern Gulf of Mexico, Santa Barbara Channel, East China Sea, and the Great Barrier Reef. The impacts of increases in anthropogenic nutrient loading (e.g., development of "dead zones," loss of biologically engineered habitats, and toxic phytoplankton events) are, and will continue to be, exacerbated by synergies with other pressures, including over fishing, coastal development and climate-driven increases in sea surface temperature, acidification and rainfall. With respect to management, reductions in point source inputs from sewage treatment plants are increasingly successful. However, controlling inputs from diffuse sources remains a challenging problem. The conclusion from this analysis is that the severity of coastal eutrophication will likely continue to increase in the absence of effectively enforced, ecosystem-based management of both point and diffuse sources of nitrogen and phosphorus. This requires sustained, integrated research and monitoring, as well as repeated assessments of nutrient loading and impacts. These must be informed and guided by ongoing collaborations among scientists, politicians, managers and the public.info:eu-repo/semantics/publishedVersio
- …